This inventor holds 2 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent. Top assignee: Lyell Immunopharma, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Innovations by Nicholas P Restifo in Cell Culture and Rejuvenation
Introduction
Nicholas P Restifo is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of cell culture and immunotherapy. With a total of 2 patents, his work focuses on advancing methods for culturing and rejuvenating T cells.
Latest Patents
Restifo's latest patents include innovative methods for culturing cells. One patent details methods of culturing pluripotent, multipotent, and immune cells in a medium with specific potassium ion concentrations. This method aims to increase the number of less-differentiated cells in the population. Another patent focuses on producing rejuvenated T cells by contacting them with reprogramming factors, which reactivate the cells for therapeutic use.
Career Highlights
Nicholas P Restifo is currently associated with Lyell Immunopharma, Inc., where he continues to push the boundaries of cell therapy. His research has the potential to transform treatments for various diseases by enhancing the efficacy of T cells.
Collaborations
Restifo has collaborated with notable colleagues, including Raul E Vizcardo Sakoda and Richard D Klausner. These partnerships have further enriched his research and development efforts in the field of immunotherapy.
Conclusion
Nicholas P Restifo's innovative work in cell culture and rejuvenation is paving the way for advancements in immunotherapy. His contributions are vital for the future of medical treatments involving T cells.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile